362 related articles for article (PubMed ID: 25686400)
1. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
2. Dehydroascorbic Acid and pGPMA Dual Modified pH-Sensitive Polymeric Micelles for Target Treatment of Liver Cancer.
Ma H; Jiang C
J Pharm Sci; 2018 Feb; 107(2):595-603. PubMed ID: 29024701
[TBL] [Abstract][Full Text] [Related]
3. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
6. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
[TBL] [Abstract][Full Text] [Related]
7. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
[TBL] [Abstract][Full Text] [Related]
8. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
9. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells.
Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H
J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722
[TBL] [Abstract][Full Text] [Related]
10. pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin.
Wu JL; Tian GX; Yu WJ; Jia GT; Sun TY; Gao ZQ
Int J Mol Sci; 2016 Mar; 17(4):364. PubMed ID: 27043540
[TBL] [Abstract][Full Text] [Related]
11. Sialic Acid-Functionalized pH-Triggered Micelles for Enhanced Tumor Tissue Accumulation and Active Cellular Internalization of Orthotopic Hepatocarcinoma.
Xu XL; Lu KJ; Zhu ML; Du YL; Zhu YF; Zhang NN; Wang XJ; Kang XQ; Xu DM; Ying XY; Yu RS; Lu CY; Ji JS; You J; Du YZ
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31903-31914. PubMed ID: 30178997
[TBL] [Abstract][Full Text] [Related]
12. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional hybrid micelles with tunable active targeting and acid/phosphatase-stimulated drug release for enhanced tumor suppression.
Liu X; Li Y; Tan X; Rao R; Ren Y; Liu L; Yang X; Liu W
Biomaterials; 2018 Mar; 157():136-148. PubMed ID: 29268144
[TBL] [Abstract][Full Text] [Related]
14. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
Yu S; Ding J; He C; Cao Y; Xu W; Chen X
Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261
[TBL] [Abstract][Full Text] [Related]
15. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
[TBL] [Abstract][Full Text] [Related]
17. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links.
Koo AN; Min KH; Lee HJ; Lee SU; Kim K; Kwon IC; Cho SH; Jeong SY; Lee SC
Biomaterials; 2012 Feb; 33(5):1489-99. PubMed ID: 22130564
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Song Q; Tan S; Zhuang X; Guo Y; Zhao Y; Wu T; Ye Q; Si L; Zhang Z
Mol Pharm; 2014 Nov; 11(11):4118-29. PubMed ID: 25222114
[TBL] [Abstract][Full Text] [Related]
19. Folate-functionalized polymeric micelles based on biodegradable PEG-PDLLA as a hepatic carcinoma-targeting delivery system.
Niu C; Sun Q; Zhou J; Cheng D; Hong G
Asian Pac J Cancer Prev; 2011; 12(8):1995-9. PubMed ID: 22292640
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice.
Wang C; Li Y; Chen B; Zou M
Colloids Surf B Biointerfaces; 2016 Oct; 146():31-8. PubMed ID: 27244048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
